Published Date: 16 Mar 2023
The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.
Read Full NewsA leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
(Refiles to remove extraneous word years from first paragraph)
The Moderna vaccine will likely be available in Europe long before the US.
Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.
Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.
In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.
Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.
1.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
2.
Children with cancer experience much less pain at home when using a pain monitoring app.
3.
Breast cancer prevention: How nurse practitioners and physician assistants can help
4.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
5.
Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?
1.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
2.
Unveiling the Complexity of Multiple Myeloma Staging
3.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
4.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
5.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation